HCT
Showing 1 - 25 of 1,347
Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)
Recruiting
- Hematologic Malignancies
- Haplo HCT <55 years old
- +4 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 25, 2023
Hematopoietic Cell Transplant Trial in Atlanta (Virtual exercise and rehabilitation program)
Not yet recruiting
- Hematopoietic Cell Transplant
- Virtual exercise and rehabilitation program
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jul 5, 2023
Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical
Not yet recruiting
- Sickle Cell Disease
- Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 4, 2023
Autism Spectrum Disorder Trial in Durham (hCT-MSC infusion)
Completed
- Autism Spectrum Disorder
- hCT-MSC infusion
-
Durham, North CarolinaDuke University Medical Center
Jan 19, 2023
Burden, Stress Trial in Tampa (FOCUS, Healthy Living)
Recruiting
- Burden
- Stress
- FOCUS
- Healthy Living
-
Tampa, FloridaMoffitt Cancer Center
Dec 30, 2022
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)
Not yet recruiting
- Sinusoidal Obstruction Syndrome
- Veno-occlusive Disease
- (no location specified)
Aug 4, 2023
Gastro-Intestinal Disorder Trial in Memphis (Fecal microbiota transplant (FMT))
Not yet recruiting
- Gastro-Intestinal Disorder
- Fecal microbiota transplant (FMT)
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 9, 2023
Hematopoietic Stem Cell Transplantation Trial in Ann Arbor (Bob's Red Mill®, Starch Placebo)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Bob's Red Mill®
- Starch Placebo
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Dec 20, 2022
Arterial Hypertension Trial (Olmesartan medoxomil 40mg + chlorthalidone 12,5mg, Olmesartan medoxomil 40mg + chlorthalidone 25mg,
Not yet recruiting
- Arterial Hypertension
- Olmesartan medoxomil 40mg + chlorthalidone 12,5mg
- +3 more
- (no location specified)
Aug 3, 2022
Hematopoietic Cell Transplantation (HCT) Trial (Tributyrin)
Not yet recruiting
- Hematopoietic Cell Transplantation (HCT)
- Tributyrin
- (no location specified)
Jul 11, 2023
Autism, Autism Spectrum Disorder Trial in Durham (Cord Tissue Mesenchymal Stromal Cells, Placebo Infusion)
Active, not recruiting
- Autism
- Autism Spectrum Disorder
- Cord Tissue Mesenchymal Stromal Cells
- Placebo Infusion
-
Durham, North CarolinaDuke University Medical Center
Oct 26, 2022
Psychotic Disorders Trial in Alexandria (Horticultural Therapy Program)
Completed
- Psychotic Disorders
- Horticultural Therapy Program
-
Alexandria, EgyptFaculty of Nursing
Oct 4, 2023
Hematopoietic Stem Cell Transplantation, Art Therapy, Physical Therapy Trial (Art and Physical Therapy, Physical Therapy)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- +2 more
- Art and Physical Therapy
- Physical Therapy
- (no location specified)
Aug 11, 2022
Autism Spectrum Disorder, Autism Trial in Durham (hCT-MSC)
Recruiting
- Autism Spectrum Disorder
- Autism
- hCT-MSC
-
Durham, North CarolinaDuke University Medical Center
Apr 19, 2022
Hematopoietic Steam Cell Transplantation (HCT) Trial in Raleigh (Acceptance and Commitment Therapy (ACT))
Recruiting
- Hematopoietic Steam Cell Transplantation (HCT)
- Acceptance and Commitment Therapy (ACT)
-
Raleigh, North CarolinaLauren Hill
Mar 29, 2022
Vascular, Endothelial, Endothelial Dysfunction Trial in Houston (Vendys II Device)
Recruiting
- Vascular
- +3 more
- Vendys II Device
-
Houston, TexasM D Anderson Cancer Center
Jun 28, 2022
Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)
Completed
- Multiple Myeloma
- Uproleselan
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
cGVHD Trial in Guanzhou (Belimumab (Benlysta))
Withdrawn
- cGVHD
- Belimumab (Benlysta)
-
Guanzhou, ChinaDepartment of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023
COVID, Corona Virus Infection, COVID19 Trial in United States (Human cord tissue mesenchymal stromal cells (hCT-MSC)
Terminated
- COVID
- +2 more
- Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University.
- Placebo
-
Boca Raton, Florida
- +4 more
Feb 17, 2022
Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)
Recruiting
- Relapsed Acute Myeloid Leukemia
- Flotetuzumab
- Donor lymphocyte infusion
-
Saint Louis, MissouriWashington University School of Medicine
Sep 7, 2022
Hematologic Cancer, Hematologic Malignancy Trial in Boston (CBT for Fatigue, Usual Care)
Not yet recruiting
- Hematologic Cancer
- Hematologic Malignancy
- CBT for Fatigue
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 3, 2023
Respiratory Failure in Pediatric Hematopoietic Cell
Recruiting
- Respiratory Failure
- Respiratory Disease
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Mar 24, 2022
Allogeneic Hematopoietic Cell Transplantation (HCT) Trial in Boston (FMT, Placebo)
Terminated
- Allogeneic Hematopoietic Cell Transplantation (HCT)
- FMT
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Nov 3, 2021
Cytomegalovirus Infection Trial in United States (DBS Self-Collection Kit, Standard Control Strategy)
Recruiting
- Cytomegalovirus Infection
- DBS Self-Collection Kit
- Standard Control Strategy
-
Minneapolis, Minnesota
- +3 more
Aug 18, 2022